Stage III rectal cancer means that cancerous cells have grown through the wall of the rectum and have spread to nearby lymph nodes, but have not yet traveled to distant organs. Treatment combines several approaches—surgery, radiation, and chemotherapy—working together to remove the tumor, destroy remaining cancer cells, and reduce the chance of the disease coming back.

Understanding Your Treatment Path

When you receive a diagnosis of stage III rectal cancer, it means the disease has moved beyond the inner layers of your rectum and reached the lymph nodes close to the tumor. This stage is different from earlier stages because it involves more tissue and requires a more comprehensive treatment strategy. The goal is not just to remove visible cancer but also to eliminate cells that may have spread to nearby areas, lowering the risk of recurrence and improving your long-term health.^[1][2]

Treatment decisions depend on several factors, including exactly where the tumor is located in your rectum, how deeply it has grown into the rectal wall, how many lymph nodes contain cancer cells, and your overall health. Your medical team will consider all of these details when recommending a treatment plan. Some patients may be candidates for surgery alone, but most will benefit from combining surgery with other therapies. The order in which you receive these treatments matters, as research shows that giving certain therapies before surgery can improve outcomes.^[3][10]

Stage III rectal cancer is further divided into subcategories—3A, 3B, and 3C—based on how far the cancer has spread through the rectal wall and how many lymph nodes are involved. Stage 3A typically means the cancer is still in the inner or muscle layers of the bowel wall and has reached one to six nearby lymph nodes. Stage 3B indicates the cancer has grown into the outer lining of the bowel wall or surrounding tissue and may involve more lymph nodes. Stage 3C means the cancer has spread more extensively, either reaching seven or more lymph nodes or growing into nearby organs.^[6][12]

There are standard treatments approved by medical societies around the world, and there are also new therapies being tested in clinical trials. Both offer hope, and your healthcare team will help you understand which options are most suitable for your situation.

Standard Treatment for Stage III Rectal Cancer

The backbone of treatment for stage III rectal cancer is a combination of surgery, radiation therapy, and chemotherapy. Chemotherapy uses drugs to kill cancer cells or stop them from growing. The specific approach and sequence depend on factors like tumor size, location, and how the cancer responds to initial treatments.^[10][11]

Surgery

Surgery is essential for removing the tumor and surrounding tissue. The type of operation depends on where the tumor is in the rectum. A bowel resection is the most common procedure, where the surgeon removes the section of the rectum containing the cancer along with nearby lymph nodes and some healthy tissue around the tumor to ensure clear margins. The two ends of the bowel are then reconnected if possible.^[15]

In some cases, particularly if the tumor is very low in the rectum near the anus, the surgeon may need to create a temporary or permanent colostomy. A colostomy is an opening in the abdominal wall that allows stool to pass into a bag worn outside the body. Many patients find this change difficult emotionally, but support and education can help you adapt. Some colostomies are temporary and can be reversed after healing is complete.^[12][15]

Chemotherapy Before Surgery (Neoadjuvant Chemotherapy)

Many patients with stage III rectal cancer receive chemotherapy before surgery. This approach, called neoadjuvant therapy, aims to shrink the tumor, making it easier for the surgeon to remove completely. It may also destroy cancer cells that have spread to nearby areas but are too small to see on scans. Shrinking the tumor before surgery can sometimes mean a less extensive operation or even allow the surgeon to avoid a permanent colostomy.^[11][15]

Common chemotherapy drugs used include 5-fluorouracil (also called 5-FU or Adrucil) and capecitabine (Xeloda). These drugs interfere with the cancer cells’ ability to grow and divide. Capecitabine is taken by mouth as a pill, while 5-fluorouracil is usually given through a vein. The treatment typically lasts several weeks.^[15][16]

Radiation Therapy

Radiation therapy uses high-energy beams to kill cancer cells or stop them from growing. For stage III rectal cancer, radiation is almost always offered, either alone or combined with chemotherapy. The goal is to target the tumor and nearby lymph nodes to reduce the risk of cancer coming back in the pelvis after surgery.^[12][15]

There are two main approaches to radiation. A short course of radiation involves five treatments given over one week, followed by surgery a week or two later. A long course involves 25 to 30 treatments over five to six weeks and is often combined with chemotherapy. This combination is called chemoradiation or chemoradiotherapy. Your doctor will recommend the approach that best fits your tumor and overall health.^[11][12]

External radiation therapy is the most common type used for rectal cancer. It directs beams from outside the body toward the tumor. Sometimes brachytherapy, where a radiation source is placed inside or near the tumor, may be used.^[15]

Chemotherapy After Surgery (Adjuvant Chemotherapy)

After surgery, many patients receive additional chemotherapy to destroy any remaining cancer cells that may be too small to detect. This is called adjuvant chemotherapy. It typically lasts around four months and uses similar drugs to those given before surgery. The goal is to reduce the chance of the cancer returning. Whether you need chemotherapy after surgery depends on what was found during the operation and whether you received chemotherapy and radiation before surgery.^[11][15]

Common chemotherapy combinations for adjuvant treatment include FOLFOX, which combines 5-fluorouracil, leucovorin (a drug that makes 5-FU work better), and oxaliplatin (a platinum-based drug). Another option is capecitabine alone or combined with oxaliplatin.^[16]

Total Neoadjuvant Therapy (TNT)

An increasingly common approach is called total neoadjuvant therapy (TNT). This means giving all planned chemotherapy and radiation before surgery rather than splitting it up. For example, you might receive chemoradiation followed by several cycles of chemotherapy, and then have surgery. Studies suggest this approach can improve outcomes by shrinking tumors more effectively and reducing the risk of cancer spreading. It may also allow some patients to delay or even avoid surgery if the tumor responds very well.^[12][16]

Possible Side Effects of Standard Treatment

All cancer treatments can cause side effects, though not everyone experiences them in the same way. Chemotherapy side effects may include nausea, vomiting, diarrhea, tiredness, loss of appetite, mouth sores, and increased risk of infection. Some drugs, like oxaliplatin, can cause tingling or numbness in the hands and feet, a condition called peripheral neuropathy. These effects usually improve after treatment ends, but some may last longer.^[16]

Radiation therapy to the pelvis can cause fatigue, skin irritation in the treated area, diarrhea, and bladder irritation. Long-term effects can include bowel changes, sexual problems, and, in rare cases, damage to nearby organs. Your medical team can offer medications and supportive care to manage these side effects.^[11]

Surgery carries risks such as infection, bleeding, and complications from anesthesia. Recovery time varies, but most people need several weeks to heal. If you have a colostomy, learning to care for it is part of the recovery process, and specialized nurses can provide guidance and support.^[18]

Promising Therapies in Clinical Trials

Beyond standard treatments, researchers are constantly testing new ways to treat stage III rectal cancer. Clinical trials are research studies that test new drugs, combinations of treatments, or different sequences of therapy to find out if they are safe and effective. Participating in a clinical trial may give you access to cutting-edge treatments before they become widely available.^[11]

Immunotherapy

Immunotherapy is a type of treatment that helps your own immune system recognize and attack cancer cells. Normally, cancer cells can hide from the immune system, but immunotherapy drugs can unmask them. One type of immunotherapy involves drugs called checkpoint inhibitors, which block proteins that prevent immune cells from attacking cancer. These drugs have shown promise in certain patients whose tumors have specific genetic features.^[11]

For rectal cancer, immunotherapy is most effective in tumors with a condition called microsatellite instability-high (MSI-H) or mismatch repair deficiency (dMMR). These genetic changes make the tumor more visible to the immune system. If your tumor has these features, your doctor may recommend testing immunotherapy drugs like pembrolizumab or nivolumab in clinical trials or as part of standard care. Early results show that some patients with MSI-H tumors respond very well, with tumors shrinking significantly or even disappearing.^[11]

Targeted Therapies

Targeted therapies are drugs designed to attack specific features of cancer cells while sparing normal cells. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapies focus on molecular changes that drive cancer growth. For rectal cancer, researchers are studying drugs that block signals that help tumors grow blood vessels, a process called angiogenesis. Drugs like bevacizumab (Avastin) work by blocking a protein called vascular endothelial growth factor (VEGF), which tumors need to build new blood vessels. Cutting off the blood supply can slow or stop tumor growth.^[11]

Other targeted drugs focus on pathways inside cancer cells that control growth. For example, drugs that block the epidermal growth factor receptor (EGFR), such as cetuximab (Erbitux), are being tested in clinical trials for rectal cancer. These drugs may be combined with chemotherapy or radiation to improve results.

Novel Combinations and Sequences

Clinical trials are also exploring new ways to combine existing treatments or change the order in which they are given. For example, some trials are testing whether adding immunotherapy to total neoadjuvant therapy can improve outcomes. Others are looking at whether giving chemotherapy before both radiation and surgery leads to better results than the traditional sequence.^[11]

These studies are conducted in phases. Phase I trials test a new treatment in a small group of people to evaluate its safety and find the best dose. Phase II trials look at whether the treatment works and continues to monitor safety. Phase III trials compare the new treatment to the current standard to see if it offers an advantage. If a Phase III trial shows that a new treatment is better, it may become a new standard of care.

Where Trials Are Conducted

Clinical trials for rectal cancer are conducted in many countries, including the United States, Europe, and other regions. Large cancer centers often lead these studies, but community hospitals may also participate. Your doctor can help you find trials that you may be eligible for and explain what participation involves.^[11]

Most Common Treatment Methods

• Surgery
  • Bowel resection to remove the tumor, nearby lymph nodes, and surrounding tissue
  • Temporary or permanent colostomy in some cases
  • The specific type depends on tumor location in the rectum
• Chemotherapy
  • 5-fluorouracil (5-FU) given intravenously
  • Capecitabine (Xeloda) taken orally
  • FOLFOX regimen combining 5-FU, leucovorin, and oxaliplatin
  • Given before surgery to shrink tumors or after surgery to prevent recurrence
• Radiation Therapy
  • Short course: five treatments over one week
  • Long course: 25 to 30 treatments over five to six weeks
  • External beam radiation is most common
  • Often combined with chemotherapy (chemoradiation)
• Total Neoadjuvant Therapy (TNT)
  • All chemotherapy and radiation given before surgery
  • May involve chemoradiation followed by chemotherapy
  • Can improve tumor shrinkage and outcomes
• Immunotherapy (in clinical trials and for specific patients)
  • Checkpoint inhibitors like pembrolizumab or nivolumab
  • Most effective for tumors with MSI-H or dMMR genetic features
  • Helps the immune system recognize and attack cancer cells
• Targeted Therapy (in clinical trials)
  • Bevacizumab blocks blood vessel growth in tumors
  • Cetuximab targets growth signals in cancer cells
  • Often combined with chemotherapy or radiation